Literature DB >> 15858014

Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions.

Geoffrey H Holm1, Dana Gabuzda.   

Abstract

Apoptosis of uninfected bystander T cells contributes to T-cell depletion during human immunodeficiency virus type 1 (HIV-1) infection. HIV-1 envelope/receptor interactions and immune activation have been implicated as contributors to bystander apoptosis. To better understand the relationship between T-cell activation and bystander apoptosis during HIV-1 pathogenesis, we investigated the effects of the highly cytopathic CXCR4-tropic HIV-1 variant ELI6 on primary CD4(+) and CD8(+) T cells. Infection of primary T-cell cultures with ELI6 induced CD4(+) T-cell depletion by direct cell lysis and bystander apoptosis. Exposure of primary CD4(+) and CD8(+) T cells to nonreplicating ELI6 virions induced bystander apoptosis through a Fas-independent mechanism. Bystander apoptosis of CD4(+) T cells required direct contact with virions and Env/CXCR4 binding. In contrast, the apoptosis of CD8(+) T cells was triggered by a soluble factor(s) secreted by CD4(+) T cells. HIV-1 virions activated CD4(+) and CD8(+) T cells to express CD25 and HLA-DR and preferentially induced apoptosis in CD25(+)HLA-DR(+) T cells in a CXCR4-dependent manner. Maximal levels of binding, activation, and apoptosis were induced by virions that incorporated MHC class II and B7-2 into the viral membrane. These results suggest that nonreplicating HIV-1 virions contribute to chronic immune activation and T-cell depletion during HIV-1 pathogenesis by activating CD4(+) and CD8(+) T cells, which then proceed to die via apoptosis. This mechanism may represent a viral immune evasion strategy to increase viral replication by activating target cells while killing immune effector cells that are not productively infected.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15858014      PMCID: PMC1091688          DOI: 10.1128/JVI.79.10.6299-6311.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  88 in total

1.  New insights into the functionality of a virion-anchored host cell membrane protein: CD28 versus HIV type 1.

Authors:  Jean-François Giguère; Jean-Sébastien Paquette; Salim Bounou; Réjean Cantin; Michel J Tremblay
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

Review 2.  Apoptosis as an HIV strategy to escape immune attack.

Authors:  Marie-Lise Gougeon
Journal:  Nat Rev Immunol       Date:  2003-05       Impact factor: 53.106

Review 3.  CD28/B7 costimulation: a review.

Authors:  E A Greenfield; K A Nguyen; V K Kuchroo
Journal:  Crit Rev Immunol       Date:  1998       Impact factor: 2.214

4.  Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods.

Authors:  H Lecoeur; E Ledru; M C Prévost; M L Gougeon
Journal:  J Immunol Methods       Date:  1997-12-01       Impact factor: 2.303

5.  In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells.

Authors:  Andreas Jekle; Oliver T Keppler; Erik De Clercq; Dominique Schols; Mark Weinstein; Mark A Goldsmith
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

6.  Increased expression of CD80 and CD86 in in vitro-infected CD3+ cells producing cytoplasmic HIV type 1 p24.

Authors:  J Jason; K L Inge
Journal:  AIDS Res Hum Retroviruses       Date:  1999-01-20       Impact factor: 2.205

7.  CD80 and CD86 costimulatory molecules on circulating T cells of HIV infected individuals.

Authors:  C Köchli; T Wendland; K Frutig; R Grunow; S Merlin; W J Pichler
Journal:  Immunol Lett       Date:  1999-02       Impact factor: 3.685

8.  Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope.

Authors:  A Ohagen; S Ghosh; J He; K Huang; Y Chen; M Yuan; R Osathanondh; S Gartner; B Shi; G Shaw; D Gabuzda
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  CCR5 mediates Fas- and caspase-8 dependent apoptosis of both uninfected and HIV infected primary human CD4 T cells.

Authors:  Alicia Algeciras-Schimnich; Stacey R Vlahakis; Angelina Villasis-Keever; Timothy Gomez; Carrie J Heppelmann; German Bou; Carlos V Paya
Journal:  AIDS       Date:  2002-07-26       Impact factor: 4.177

10.  Changes in thymic function with age and during the treatment of HIV infection.

Authors:  D C Douek; R D McFarland; P H Keiser; E A Gage; J M Massey; B F Haynes; M A Polis; A T Haase; M B Feinberg; J L Sullivan; B D Jamieson; J A Zack; L J Picker; R A Koup
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

View more
  35 in total

Review 1.  Defective virus drives human immunodeficiency virus infection, persistence, and pathogenesis.

Authors:  Diana Finzi; Susan F Plaeger; Carl W Dieffenbach
Journal:  Clin Vaccine Immunol       Date:  2006-07

2.  Perturbations of cell cycle control in T cells contribute to the different outcomes of simian immunodeficiency virus infection in rhesus macaques and sooty mangabeys.

Authors:  M Paiardini; B Cervasi; B Sumpter; H M McClure; D L Sodora; M Magnani; S I Staprans; G Piedimonte; G Silvestri
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

3.  Deep sequencing of HIV-infected cells: insights into nascent transcription and host-directed therapy.

Authors:  Xinxia Peng; Pavel Sova; Richard R Green; Matthew J Thomas; Marcus J Korth; Sean Proll; Jiabao Xu; Yanbing Cheng; Kang Yi; Li Chen; Zhiyu Peng; Jun Wang; Robert E Palermo; Michael G Katze
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

4.  Distinctive in vitro effects of T-cell growth cytokines on cytomegalovirus-stimulated T-cell responses of HIV-infected HAART recipients.

Authors:  Julie Patterson; Renee Jesser; Adriana Weinberg
Journal:  Virology       Date:  2008-06-24       Impact factor: 3.616

5.  Inhibition of envelope-mediated CD4+-T-cell depletion by human immunodeficiency virus attachment inhibitors.

Authors:  Louis Alexander; Sharon Zhang; Brian McAuliffe; David Connors; Nannon Zhou; Tao Wang; Michele Agler; John Kadow; Pin-Fang Lin
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

6.  Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy.

Authors:  Adriana A Byrnes; David M Harris; Sowsan F Atabani; Beulah P Sabundayo; Susan J Langan; Joseph B Margolick; Christopher L Karp
Journal:  J Leukoc Biol       Date:  2008-09-19       Impact factor: 4.962

7.  T-cell activation, both pre- and post-HAART levels, correlates with carotid artery stiffness over 6.5 years among HIV-infected women in the WIHS.

Authors:  Roksana Karim; Wendy J Mack; Naoko Kono; Phyllis C Tien; Kathryn Anastos; Jason Lazar; Mary Young; Seema Desai; Elizabeth T Golub; Robert C Kaplan; Howard N Hodis; Andrea Kovacs
Journal:  J Acquir Immune Defic Syndr       Date:  2014-11-01       Impact factor: 3.731

8.  Immunodeficiency in the absence of high viral load in pig-tailed macaques infected with Simian immunodeficiency virus SIVsun or SIVlhoest.

Authors:  Brigitte E Beer; Charles R Brown; Sonya Whitted; Simoy Goldstein; Robert Goeken; Ronald Plishka; Alicia Buckler-White; Vanessa M Hirsch
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

9.  Class II transactivator (CIITA) enhances cytoplasmic processing of HIV-1 Pr55Gag.

Authors:  Kristen A Porter; Lauren N Kelley; Annette George; Jonathan A Harton; Karen M Duus
Journal:  PLoS One       Date:  2010-06-24       Impact factor: 3.240

10.  Cell-to-Cell Transmission of HIV-1 Is Required to Trigger Pyroptotic Death of Lymphoid-Tissue-Derived CD4 T Cells.

Authors:  Nicole Lk Galloway; Gilad Doitsh; Kathryn M Monroe; Zhiyuan Yang; Isa Muñoz-Arias; David N Levy; Warner C Greene
Journal:  Cell Rep       Date:  2015-08-28       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.